PSYCHEDELIKATESY// Milan Scheidegger: Transformational Psychotherapy

31. května se v pražském prostoru DUP39 uskuteční jedinečná přednáška předního odborníka na využití psychedelik v psychoterapii, doktora Milana Scheideggera.

Doktor Milan Scheidegger je známý česko-švýcarský lékař, který se věnuje neurobiologii a farmakologii změnených stavů vědomí. Je členem výzkumného institutu Heffter Research Center (HRC) a působí také na oddělení psychiatrie, psychoterapie a psychosomatiky v Univerzitní psychiatrické nemocnici v Curychu (University Hospital of Psychiatry, Zurich).

Ve své práci se doktor Scheidegger soustředí zejména na otázku, jakým způsobem mohou látky jako ketamin, psilocybin, ayahuasca či DMT, pomáhat v psychoterapii. Jeho zkušenosti se neomezují pouze na prostředí laboratoře, ale na výzkumných cestách do Mexika, Kolumbie a Brazílie získal cenné informace o využití psychoaktivních rostlin také v tradičním kontextu amazonské medicíny. Přednáška se bude věnovat účinku psychedelik z pohledu současné neurovědy a potenciálu těchto látek posunout se z paradigmatu substitučního využití v psychoterapii, do role transformativní.

Ucelené informace o přednášce, naleznete níže v anglickém jazyce, ve kterém bude probíhat i samotná přednáška. 

Soutěž o vstupenky.

Kdy: 31. 5. 2017
Kde: DUP39, Praha
Vstupenky: dospělí – 144 Kč, studenti, ZTP – 111 Kč, členové CZEPS 90 Kč. Koupit zde.
Přednáška proběhne v angličtině.
Sledujte aktuality a události na Facebooku.

_____________________________________________________

English version

Transformational Psychotherapy:
Converging roles of mindfulness and psychedelics for mental health care

In the context of the renaissance of psychedelic research we are currently facing a paradigm shift in the understanding of consciousness and psychotherapeutic transformation. As Freuds dream theory deepened the psychoanalytic understanding of the unconscious, psychedelics could nowadays serve as the via regia for the scientific exploration of the human mind. In particular, advanced neuroimaging technologies provide exciting novel insights into the brain dynamics underlying pharmacologically induced altered states of consciousness. Beyond that, psychedelics also raise profound philosophical and existential questions about the nature of subjective experience and the creation of meaning in the universe.

In my talk, I will give an overview about how the subjective and clinical effects of psychedelics such as ketamine, psilocybin and ayahuasca can be explained from the perspective of contemporary neuroscience. Next, I will discuss the potential of psychedelics to shift the paradigm from substitution to transformation-based psychotherapy. As both rapid-acting and sustainable catalysts, psychedelics offer new avenues for therapeutic transformation by targeting various levels of disconnection in modern societies and restoring the sense of connectedness to ourselves and our environment.

Finally, under supportive conditions, psychedelics can induce personally meaningful and profound mystical-type experiences that share a striking resemblance to states reached in very deep meditation. Indeed, our recent studies show that psilocybin has the potential to facilitate mindfulness in experienced meditators in a meditation retreat setting. This underscores the converging roles of psychedelics and mindfulness for integrative transformational healthcare.
_______________________________________________________________
Biography

Milan Scheidegger has a dual Swiss-Czech citizenship and holds an M.D. degree from the University of Zurich. He completed his Ph.D. in functional and molecular neuroimaging at the Institute for Biomedical Engineering (University and ETH Zurich). As an affiliated member of the Heffter Research Center (HRC) and resident physician at the Department of Psychiatry, Psychotherapy, and Psychosomatics (University Hospital of Psychiatry Zurich) he is currently researching the neurobiology and pharmacology of altered states of consciousness. He is member of the Swiss Society for Psycholytic Therapy (SAEPT) and investigates the potential of psychedelics such as ketamine, psilocybin, ayahuasca and DMT to facilitate therapeutic transformation. On his ethnobotanical expeditions to Mexico, Colombia and Brazil he explored the traditional use of psychoactive plants in shamanic rituals. In addition to empirical research, he earned an M.A. degree in History and Philosophy of Knowledge (ETH Zurich). His main interests include biosemiotics, epistemology and phenomenology of consciousness, mindfulness and deep ecology.

The talk will be held in English.